RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 D835Y

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 04:57:33 GMT 2025` Edited by `admin` on `Wed Apr 02 04:57:33 GMT 2025`
Protein Sub Type
Sequence Origin	HUMAN
Sequence Type	COMPLETE
Record UNII	DNV5PYD2QS
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CD135 D835Y

Preferred Name

English

RECEPTOR-TYPE TYROSINE-PROTEIN KINASE FLT3 D835Y

Common Name

English

FLT3 D835Y

Common Name

English

FLK2 D835Y

Common Name

English

FETAL LIVER KINASE-2 D835Y

Common Name

English

FLT-3 D835Y

Common Name

English

STEM CELL TYROSINE KINASE 1 D835Y

Common Name

English

FL CYTOKINE RECEPTOR D835Y

Common Name

English

FMS-LIKE TYROSINE KINASE 3 D835Y

Common Name

English

Code System Code Type Description

FDA UNII

DNV5PYD2QS

Created by admin on Wed Apr 02 04:57:33 GMT 2025 , Edited by admin on Wed Apr 02 04:57:33 GMT 2025

PRIMARY

PHAROS

P36888

Created by admin on Wed Apr 02 04:57:33 GMT 2025 , Edited by admin on Wed Apr 02 04:57:33 GMT 2025

PRIMARY

UNIPROT

P36888

Created by admin on Wed Apr 02 04:57:33 GMT 2025 , Edited by admin on Wed Apr 02 04:57:33 GMT 2025

PRIMARY

From	To
1_9	1_39
1_77	1_88
1_173	1_180
1_206	1_215
1_246	1_304
1_342	1_381
1_355	1_366

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_17
N	1_74
N	1_125
N	1_280
N	1_297
N	1_325
N	1_328
N	1_447
N	1_476
N	1_515

Related Record Type Details


					G22N65IL3O

PACRITINIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					8QR88H79VX

MIVAVOTINIB

INHIBITOR -> TARGET


					ID912S5VON

MIDOSTAURIN

INHIBITOR -> TARGET


					CDI2Y58ICE

BPR-1K871

INHIBITOR -> TARGET


					P9I9Z3MF7Z

Emirodatamab

LIGAND->TARGET


					9M7X64VTLI

Dapolsertib

INHIBITOR -> TARGET

Qualification:

Kd

Amount:


					DL772G3NN7

Nefextinib

INHIBITOR -> TARGET


					66D92MGC8M

GILTERITINIB

INHIBITOR -> TARGET


					D9B1PJ9MWX

CGP-52421

INHIBITOR -> TARGET


					4MO0WIY820

JAK-IN-28

INHIBITOR -> TARGET

Amount:


					S7MM9VTS3Z

Flonoltinib

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					5277GPA358

CENISERTIB

INHIBITOR -> TARGET

Interaction Type:

COMPETITIVE INHIBITOR

Qualification:

IC50

Amount:


					2D9N67F58G

KW-2449

INHIBITOR -> TARGET


					C0WUS7XXE9

Tuspetinib

INHIBITOR -> TARGET

Comments:

ALSO ACTIVE AGAINST FLT3 ITD and FLT3 D835Y kinases were 1.8 nM and 1.0 nM

Amount:


					6MC966B505

FN-1501

INHIBITOR -> TARGET


					6L1XP550I6

FEDRATINIB

INHIBITOR -> TARGET


					H3W3QJ5C7G

CGP-62221

INHIBITOR -> TARGET

Structural Modifications

Modification Type	Location Site	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_563] [1_565] [1_573] [1_700] [1_816] [1_929] [1_943]	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_546] [1_742] [1_767]	TYROSINE O-PHOSPHATE	2R86C98KDX
AMINO ACID SUBSTITUTION	[1_548] [1_733] [1_967]	DEXFOSFOSERINE	VI4F0K069V

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL